HL7 CDA Pharmacy Template STU2

1. Published Name of the Standard for which request is being made (if previously published) HL7 CDA® R2 Implementation Guide: Pharmacy Templates, Edition 1 2. Standards Material/Document STU 3. Date of Request Mar 20, 2023 4. Use Period two years 5. Reason for extension, timeline, and actions 6. Original Publication Date 7. End date of the current STU period 8. Length of the requested extension 9. Review Process 10. HL7 Work Group making this request and date Pharmacy WG 10a. Requesting WG Date Mar 20, 2023 11. URL of approval minutes https://confluence.hl7.org/pages/viewpage.action?pageId=161058405 12. HL7 Product Management Group CDA MG 12a. Management Group Date of Approval Apr 05, 2023 13. URL of approval minutes https://confluence.hl7.org/display/CDA/2023-04-05+CMG+Meeting+Notes 14. Is the artifact ready for final publication? Yes 15. If not ready, please describe remaining steps. 16. Tool name used to produce the machine processable artifacts in the IG ART DECOR 17. The name of the “IG artifact” within the context of the above mentioned tool. Medication on CDA https://art-decor.org/art-decor/decor-project--pharmcda- 18. Balloted Name of the standard for which request is being made HL7 CDA® R2 Implementation Guide: Pharmacy Templates, Release 1 STU Release 2 19. Requested name for published standard. See Naming Examples HL7 CDA® R2 Implementation Guide: Pharmacy Templates, Edition 1 STU Release 2 19a. Specification Feedback Name (For Search in Jira) 20. If CMET, list IDs balloted 21. Project Insight Number 1139 22. Document Realm UV 23. Ballot cycle in which the document was successfully balloted 2022-Sep 25. Affirmative 33 26. Negative 10 27. Abstentions 37 28. Not Returned 23 29. Total in ballot pool 103 30. Date on which final document/standards material was supplied to HQ Mar 10, 2023 31. URL of publication material/ SVN repository https://github.com/HL7/CDA-pharma/blob/main/input/CDAR2_IG_PHARM_TEMPLATES_E1_STU2_2023APR.zip 32. Publishing Facilitator Giorgio Cangioli 33. Special Publication Instructions 34. URL of ballot reconciliation document http://www.hl7.org/documentcenter/public/ballots/2022SEP/reconciliation/recon_cdar2_ig_pharm_templates_r1_d3_2022sep.xls 35. Has the Work Group posted its consideration of all comments received in its reconciliation document on the ballot desktop? Yes 36. Substantive Changes Since Last Ballot? No 37. Product Brief Reviewed By Pharmacy WG 38. Date Product Brief Reviewed Mar 20, 2023 39. Has the Product Brief changed? 40. Family CDA 41. Section Implementation Guides 42. Topic Pharmacy 43. Please Describe the Topic 44. Product Type Implementation Guide 45. Parent standard HL7 CDA R2 46. Parent Standard Status Move to Stable 47. Update/replace standard 48. Common name/search keyword "HL7 CDA® R2 IG: Pharmacy Templates, R1", Pharmacy Templates Templates Pharmacy CDA Templates Pharmacy Universal Templates 49. Description This Implementation Guide provides CDA R2 templates for Medication Order and Medication Statement, Medication Dispense and Medication Administration that can be used by HL7 standards developers and external projects to develop models for pharmacy related content. The implementation guide is intended to provide consistency of pharmacy related models across all uses regardless of the method of transport by creating a library of Universal (UV) Pharmacy Templates that can be used by other Work Groups to derive constrained versions. 50. Stakeholders Clinical and Public Health Laboratories, Standards Development Organizations (SDOs), Payors 51. Vendors Pharmaceutical, EHR, PHR, Health Care IT 52. Providers Healthcare Institutions (hospitals, long term care, home care, mental health) 53. Benefits Enables HL7 standards developers and external projects to develop models for pharmacy related content. Provides consistency of pharmacy related models across all uses regardless of the method of transport by creating a library of Universal (UV) Pharmacy Templates that can be used by other Work Groups to derive constrained versions 54. Implementations/Case Studies HL7 International – International Patient Summary (IPS) European Cross Border Services (MyHealth@EU) 55. Development Background Historically multiple HL7 Work Groups have developed specifications for pharmacy related content and as a result, there is inconsistency in how medication related content is represented in HL7 V2, V3, CDA and FHIR. The Pharmacy Work Group often receives questions as to how to model pharmacy related content but in some cases, the use case cannot be met with the existing models. This Implementation Guide provides a CDA R2 library of pharmacy templates that can be used by HL7 Work Groups or external projects to derive constrained versions of models for pharmacy related content.